| Sarah Elizabeth Brumbaugh-baker, CRNA | |
|
2100 Ocoee Apopka Rd, Apopka, FL 32703-9210 | |
| (407) 609-7000 | |
| Not Available |
| Full Name | Sarah Elizabeth Brumbaugh-baker |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 2 Years |
| Location | 2100 Ocoee Apopka Rd, Apopka, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750039368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | RN9388839 (Florida) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | APRN11019427 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Adventhealth Waterman | Tavares, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Us Anesthesia Partners Of Florida Inc | 0345143152 | 786 |
News Archive
Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.
Researchers from USC and the Technion Medical School in Israel have uncovered new clues into the mystery of the brain's ultra-complicated cells known as neurons.
Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today that it has completed patient enrollment for its Phase II trial of CF101 in the treatment of glaucoma.
› Verified 5 days ago
| Entity Name | Us Anesthesia Partners Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518910520 PECOS PAC ID: 0345143152 Enrollment ID: O20040129000594 |
News Archive
Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.
Researchers from USC and the Technion Medical School in Israel have uncovered new clues into the mystery of the brain's ultra-complicated cells known as neurons.
Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today that it has completed patient enrollment for its Phase II trial of CF101 in the treatment of glaucoma.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Elizabeth Brumbaugh-baker, CRNA 851 Trafalgar Ct Ste 200e, Maitland, FL 32751-7420 Ph: (407) 667-0444 | Sarah Elizabeth Brumbaugh-baker, CRNA 2100 Ocoee Apopka Rd, Apopka, FL 32703-9210 Ph: (407) 609-7000 |
News Archive
Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.
Researchers from USC and the Technion Medical School in Israel have uncovered new clues into the mystery of the brain's ultra-complicated cells known as neurons.
Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today that it has completed patient enrollment for its Phase II trial of CF101 in the treatment of glaucoma.
› Verified 5 days ago
Mr. Anthony Wayne Winston, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3116 Oak Alley Dr, Apopka, FL 32703 Phone: 407-473-8400 | |
Raymond A. Heers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 522 S Hunt Club Blvd, #572, Apopka, FL 32703 Phone: 407-620-3123 | |
Odevelyne Bresca Saint-sauveur, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 818 Haven Oak Ct, Apopka, FL 32703 Phone: 407-953-9093 | |
Craig R. Myers, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1367 Longhill Dr, Apopka, Apopka, FL 32712 Phone: 407-880-7358 | |
Paul Winter, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 842 Palm Oak Dr, Apopka, FL 32712 Phone: 407-814-2250 |